FAQ Risk of Malnutrition and Nutritional Considerations for Patients on Surgically and Medically Prescribed Weight Loss Therapies: A Guide for Clinicians
How Zepbound Is Bringing Attention to Sleep Apnea By Jordan Stern, CEO and Medical Director The FDA granted Eli Lilly an early holiday gift in 2024 The fast-track approval of the popular GLP-1 weight-loss drug Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity
Semaglutide is a peptide that belongs to a class of medications known as glucagon-like peptide-1 receptor agonists or better known as GLP-1 RAs
When you're working with novel compounds like the triple agonist peptide Retatrutide, the slightest miscalculation can cascade into skewed data, wasted resources, and invalidated experiments
This lack of satiety should be considered at school, work and home, and all caretakers and supervisors need to understand these factors
Understanding this distinction helps in selecting the right ingredient based on whether the concern is general dullness or specific areas of pigmentation
